Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Patent
1996-05-02
1999-01-12
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
514 54, 536117, A61K 3900
Patent
active
058583785
ABSTRACT:
The present invention provides a vaccine composition for enhancing the immune response of a mammal against a selected antigen. The vaccine composition of the invention comprises a combination of the selected antigen and a Candida spp. antigen. Selected antigens include, for example, a bacteria, yeast, rickettsia, protozoa, virus, parasite or components thereof. The composition may also contain adjuvants known in the art. A preferred vaccine composition for immunization against the selected antigen Cryptosporidium parvum is disclosed. The invention also provides a method for enhancing the immune response of a mammal against a selected antigen utilizing the vaccine compositions of the invention.
REFERENCES:
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4678748 (1987-07-01), Sutker et al.
patent: 4739046 (1988-04-01), DiLuzio
patent: 4761402 (1988-08-01), Williams et al.
patent: 4877612 (1989-10-01), Berger et al.
patent: 4877777 (1989-10-01), Di Luzio
patent: 4971956 (1990-11-01), Suzuki et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5106616 (1992-04-01), McAnalley et al.
patent: 5106618 (1992-04-01), Beck et al.
patent: 5217898 (1993-06-01), Kaslow et al.
patent: 5288639 (1994-02-01), Burnie et al.
patent: 5374423 (1994-12-01), Klimpel et al.
patent: 5429818 (1995-07-01), Inzana
patent: 5470835 (1995-11-01), Kirkpatrick et al.
patent: 5531988 (1996-07-01), Paul
patent: 5538733 (1996-07-01), Emery et al.
patent: 5591434 (1997-01-01), Jenkins
K. W. Angus, "Cryptosporidiosis and AIDS," Bailliere's Clinical Gastroenterology, 4:425-441 (Jun. 1990).
Barrios et al. Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guerin priming, Eur. J. Immunol. 22: 1365-72 (1992).
Florence G. Crawford et al., "Human Cryptosporidiosis," CRC Critical Reviews in Microbiology, 16:113-159 (1988).
Edward N. Janoff et al., "Cryptosporidium Species, a Protean Protozoan," Journal of Clinical Microbiology, 25:967-975 (Jun. 1987).
Barbara E. Laughon et al., "Prevalence of Enteric Pathogens in Homosexual Men With and Without Acquired Immunodeficiency Syndrome," Gastroenterology, 94:984-992 (Apr. 1988).
Jill Nord et al., "Treatment with Bovine Hyperimmune Colostrum of Cryptosporidial Diarrhea in AIDS Patients," AIDS, 4:581-584 (1990).
Roger J. Panciera, D.V.M., M.S., Ph.D., "Cryptosporidiosis," Current Veterinary Therapy, 779-780, (1981).
Carolyn Petersen, "Cryptosporidiosis in Patients Infected with the Human Immunodeficiency Virus," Clinical Infectious Diseases, 15:903-909 (Dec. 1992).
Oblack et al. "Active Immunization of Mice Against Muscle Damage Mediated by Candida Albicans:" J. Med Microbiol., 12(4): 503-506 (1979).
James J. Plorde, "Cryptosporidiosis," Harrison's Principles of Internal Medicine, 1:803-805, (Twelfth Edition, 1991).
Rosemary Soave et al., "Cryptosporidium and Other Protozoa Including Isospora, Sarcocystis, Balantidium Coli, and Blastocystis," Principles and Practices of Infectious Diseases, 2122-2130 (Third Edition, 1990).
Saul Tzipori et al., "Chronic Cryptosporidial Diarrhoea and Hyperimmune Cow Colostrum," The Lancet, 344-345 (Aug. 8, 1987).
Beth L. P. Ungar et al., "Cessation of Cryptosporidium-Associated Diarrhea in an Acquired Immunodeficiency Syndrome Patient After Treatment With Hyperimmune Bovine Colostrum," Gastroenterology, 98:486-489 (Feb. 1990).
Ashman, R. B. et al, Microbiol. Review, Dec. 1995, vol. 59(4), pp. 646-672.
Segal, E, Crit. Review, Microbiol., 1987, vol. 14(3), pp. 229-271.
Harp, JA et al, J. Parasitat, vol. 81(1) pp. 54-57, 1995.
Williams, DL et al, Int. J. Immunopharmac., vol. (4), pp. 403-410, 1989.
Scaringi, L et al, J. Gen. Microbiol, England, May, vol. 134(pt. 5), pp. 1265-1274, 1988.
Yamaguchi, H. et al, Ann. N.Y., Acad. Sci., Jun. 23, 1993, vol. 685, pp. 447-457.
Cook, JA et al, Surv. Immunol. Res., vol. 2, pp. 243-245 1983.
Cook, JA et al, Int. J. Immunopharm, vol. 4(4), p. 270, #68, 1982.
Cook, JA et al., J. of the Reticuloendothelial Society vol. 27(6), Jun. 1980.
Holbrook, TW et al, Am. J. Trop. Med. Hyg., vol. 32(1), pp. 51-53, 1983.
Holbrook, TW et al, Infect. & Immun., vol. 32(2) pp. 542-546, May 1981.
Jareckiv, Black, JC et al, Ann. Clin. Lab. Sci, vol. 18(1), pp. 72-77, 1988.
Maheshwari, R et al, Indian J. of Med. Res., Sect. A, Infectious disease, vol. 89, Nov., pp. 396-403, 1989.
Vazquez, N et al, J. Med & Vet. Mycology, vol. 33, #6, pp. 385-393, 1995.
Obaid, KA et al, Int. J. Immunpharm, vol. 11(3), pp. 229-235, 1989.
Cutler, J. E. et al., Infect. Immun., vol. 38(3), Dec. 1982, pp. 1102-1108.
Harp, J.A. et al, J. Parasitol, vol. 81(1), 1995, pp. 54-57.
Mencacci, A. et al, Infect. Immun., Dec. 1994, vol. 62(12) pp. 5353-5360.
Carrow, E.W. et al, Infect Immun, Jul. 1985, vol. 49(1), pp. 172-181.
Galagen, Inc.
Housel James C.
Portner Ginny Allen
LandOfFree
Pharmaceutical composition comprising cryptosporidium parvum ooc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising cryptosporidium parvum ooc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising cryptosporidium parvum ooc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1512226